Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 141 | 2024 | 8717 | 5.590 |
Why?
|
Amyloid beta-Peptides | 86 | 2024 | 3887 | 4.100 |
Why?
|
tau Proteins | 43 | 2024 | 2107 | 2.960 |
Why?
|
Neuropsychological Tests | 88 | 2024 | 7119 | 2.820 |
Why?
|
Positron-Emission Tomography | 95 | 2024 | 6550 | 2.750 |
Why?
|
Cognition | 50 | 2024 | 7057 | 2.260 |
Why?
|
Memory | 28 | 2023 | 2192 | 1.850 |
Why?
|
Memory Disorders | 26 | 2024 | 1193 | 1.780 |
Why?
|
Aging | 47 | 2024 | 8731 | 1.690 |
Why?
|
Cognition Disorders | 26 | 2019 | 3967 | 1.550 |
Why?
|
Amyloid | 15 | 2024 | 849 | 1.540 |
Why?
|
Aniline Compounds | 38 | 2024 | 1079 | 1.530 |
Why?
|
Locus Coeruleus | 9 | 2024 | 241 | 1.460 |
Why?
|
Disease Progression | 40 | 2024 | 13640 | 1.330 |
Why?
|
Activities of Daily Living | 17 | 2024 | 2429 | 1.230 |
Why?
|
Brain | 56 | 2024 | 27159 | 1.200 |
Why?
|
Association Learning | 5 | 2015 | 219 | 1.200 |
Why?
|
Mental Recall | 10 | 2020 | 1218 | 1.190 |
Why?
|
Apathy | 9 | 2024 | 107 | 1.030 |
Why?
|
Aged, 80 and over | 124 | 2024 | 59550 | 1.010 |
Why?
|
Thiazoles | 33 | 2024 | 1529 | 0.990 |
Why?
|
Longitudinal Studies | 58 | 2024 | 14762 | 0.850 |
Why?
|
Aged | 182 | 2024 | 171343 | 0.850 |
Why?
|
Entorhinal Cortex | 8 | 2024 | 285 | 0.720 |
Why?
|
Psychomotor Performance | 11 | 2019 | 1885 | 0.660 |
Why?
|
Magnetic Resonance Imaging | 59 | 2024 | 36567 | 0.640 |
Why?
|
Amyloidogenic Proteins | 3 | 2023 | 151 | 0.620 |
Why?
|
Tauopathies | 5 | 2021 | 325 | 0.610 |
Why?
|
Face | 5 | 2017 | 1029 | 0.600 |
Why?
|
Apolipoprotein E4 | 12 | 2020 | 709 | 0.590 |
Why?
|
Temporal Lobe | 14 | 2024 | 1716 | 0.590 |
Why?
|
Psychological Tests | 2 | 2017 | 642 | 0.570 |
Why?
|
Parietal Lobe | 8 | 2024 | 859 | 0.560 |
Why?
|
Intelligence | 4 | 2010 | 925 | 0.560 |
Why?
|
Male | 175 | 2024 | 364142 | 0.560 |
Why?
|
Hippocampus | 17 | 2024 | 3776 | 0.550 |
Why?
|
Cerebral Cortex | 14 | 2024 | 5753 | 0.540 |
Why?
|
Female | 175 | 2024 | 396520 | 0.540 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2022 | 698 | 0.520 |
Why?
|
Attention | 15 | 2024 | 2413 | 0.520 |
Why?
|
United States Food and Drug Administration | 1 | 2024 | 1673 | 0.510 |
Why?
|
Amyloidosis | 5 | 2018 | 877 | 0.510 |
Why?
|
Humans | 222 | 2024 | 766766 | 0.490 |
Why?
|
Telephone | 1 | 2019 | 629 | 0.490 |
Why?
|
Plaque, Amyloid | 4 | 2024 | 769 | 0.490 |
Why?
|
Names | 5 | 2020 | 54 | 0.470 |
Why?
|
Social Class | 1 | 2024 | 2007 | 0.470 |
Why?
|
Dementia | 9 | 2024 | 2741 | 0.470 |
Why?
|
Biomedical Technology | 1 | 2016 | 210 | 0.450 |
Why?
|
Cross-Sectional Studies | 39 | 2024 | 26310 | 0.450 |
Why?
|
Executive Function | 10 | 2018 | 1396 | 0.450 |
Why?
|
Semantics | 3 | 2019 | 609 | 0.420 |
Why?
|
Clinical Trials as Topic | 8 | 2024 | 8045 | 0.410 |
Why?
|
Loneliness | 4 | 2022 | 211 | 0.390 |
Why?
|
Presenilin-1 | 6 | 2020 | 665 | 0.390 |
Why?
|
Cognitive Reserve | 4 | 2024 | 92 | 0.390 |
Why?
|
Apolipoproteins E | 6 | 2020 | 1459 | 0.390 |
Why?
|
Atrophy | 9 | 2024 | 1631 | 0.390 |
Why?
|
Intelligence Tests | 4 | 2007 | 504 | 0.380 |
Why?
|
Carbolines | 8 | 2024 | 288 | 0.380 |
Why?
|
Research | 1 | 2020 | 1977 | 0.380 |
Why?
|
Neurodegenerative Diseases | 2 | 2024 | 1089 | 0.370 |
Why?
|
Menopause | 3 | 2023 | 1657 | 0.370 |
Why?
|
Verbal Learning | 3 | 2014 | 459 | 0.360 |
Why?
|
Ethylene Glycols | 5 | 2024 | 196 | 0.360 |
Why?
|
Heterozygote | 7 | 2020 | 2795 | 0.340 |
Why?
|
Middle Aged | 88 | 2024 | 223257 | 0.340 |
Why?
|
Psychiatric Status Rating Scales | 13 | 2018 | 6020 | 0.330 |
Why?
|
Evoked Potentials | 8 | 2014 | 1050 | 0.320 |
Why?
|
Radiopharmaceuticals | 10 | 2020 | 2704 | 0.320 |
Why?
|
Awareness | 3 | 2018 | 653 | 0.320 |
Why?
|
Reaction Time | 13 | 2023 | 2085 | 0.300 |
Why?
|
Psychometrics | 8 | 2023 | 3060 | 0.290 |
Why?
|
Brain Stem | 1 | 2013 | 858 | 0.290 |
Why?
|
Diagnostic Self Evaluation | 4 | 2020 | 228 | 0.290 |
Why?
|
Educational Measurement | 1 | 2014 | 1259 | 0.280 |
Why?
|
Self Report | 8 | 2024 | 3771 | 0.270 |
Why?
|
Nerve Net | 8 | 2024 | 2307 | 0.260 |
Why?
|
Educational Status | 5 | 2024 | 2510 | 0.260 |
Why?
|
Frontal Lobe | 5 | 2024 | 1408 | 0.260 |
Why?
|
Cues | 3 | 2017 | 877 | 0.250 |
Why?
|
Photic Stimulation | 13 | 2015 | 1989 | 0.220 |
Why?
|
Depression | 8 | 2024 | 8228 | 0.220 |
Why?
|
Fluorodeoxyglucose F18 | 7 | 2017 | 2028 | 0.220 |
Why?
|
Asymptomatic Diseases | 4 | 2024 | 588 | 0.210 |
Why?
|
Mental Status Schedule | 4 | 2017 | 315 | 0.210 |
Why?
|
Reference Standards | 1 | 2006 | 1010 | 0.210 |
Why?
|
Neocortex | 3 | 2024 | 414 | 0.200 |
Why?
|
Perfusion | 1 | 2007 | 1409 | 0.200 |
Why?
|
Linear Models | 12 | 2019 | 5874 | 0.200 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2007 | 1143 | 0.200 |
Why?
|
Cost of Illness | 4 | 2020 | 1949 | 0.200 |
Why?
|
Neural Pathways | 5 | 2024 | 3079 | 0.200 |
Why?
|
Learning Curve | 1 | 2023 | 232 | 0.190 |
Why?
|
Occupations | 1 | 2024 | 516 | 0.190 |
Why?
|
Reproducibility of Results | 12 | 2023 | 20144 | 0.190 |
Why?
|
Neurons | 5 | 2013 | 9515 | 0.180 |
Why?
|
Reference Values | 6 | 2011 | 4913 | 0.170 |
Why?
|
Agnosia | 2 | 2018 | 67 | 0.170 |
Why?
|
Widowhood | 1 | 2020 | 51 | 0.170 |
Why?
|
Risk | 6 | 2020 | 9602 | 0.170 |
Why?
|
Geriatric Assessment | 3 | 2016 | 1422 | 0.170 |
Why?
|
Parahippocampal Gyrus | 1 | 2020 | 117 | 0.170 |
Why?
|
Anxiety | 4 | 2018 | 4670 | 0.170 |
Why?
|
Scopolamine | 1 | 2019 | 92 | 0.160 |
Why?
|
Principal Component Analysis | 3 | 2017 | 949 | 0.150 |
Why?
|
Life Style | 2 | 2024 | 3926 | 0.150 |
Why?
|
Cholinergic Antagonists | 1 | 2019 | 165 | 0.150 |
Why?
|
Brain Mapping | 12 | 2017 | 6596 | 0.150 |
Why?
|
Cohort Studies | 15 | 2024 | 41710 | 0.150 |
Why?
|
Lewy Body Disease | 2 | 2012 | 252 | 0.150 |
Why?
|
Cerebrovascular Circulation | 2 | 2024 | 2672 | 0.150 |
Why?
|
Sex Characteristics | 4 | 2023 | 2645 | 0.140 |
Why?
|
Exploratory Behavior | 3 | 2009 | 271 | 0.140 |
Why?
|
Corpus Striatum | 2 | 2018 | 1218 | 0.140 |
Why?
|
Caregivers | 5 | 2024 | 2303 | 0.140 |
Why?
|
Drug Approval | 1 | 2024 | 820 | 0.140 |
Why?
|
Social Participation | 1 | 2019 | 187 | 0.140 |
Why?
|
Factor Analysis, Statistical | 3 | 2018 | 1001 | 0.140 |
Why?
|
Pilot Projects | 4 | 2019 | 8728 | 0.130 |
Why?
|
Advance Care Planning | 1 | 2024 | 698 | 0.130 |
Why?
|
Learning | 2 | 2017 | 1754 | 0.130 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2019 | 606 | 0.130 |
Why?
|
Automobile Driving | 1 | 2000 | 442 | 0.120 |
Why?
|
Treatment Outcome | 3 | 2024 | 65273 | 0.120 |
Why?
|
Health | 1 | 2018 | 397 | 0.120 |
Why?
|
Patient Participation | 1 | 2024 | 1445 | 0.120 |
Why?
|
Translations | 1 | 2015 | 84 | 0.120 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2017 | 8926 | 0.120 |
Why?
|
Eye Movements | 1 | 2018 | 510 | 0.120 |
Why?
|
Computers, Handheld | 1 | 2017 | 211 | 0.120 |
Why?
|
Sex Factors | 5 | 2019 | 10619 | 0.120 |
Why?
|
Human Development | 1 | 2015 | 122 | 0.120 |
Why?
|
Sensitivity and Specificity | 5 | 2017 | 14652 | 0.120 |
Why?
|
Combat Disorders | 1 | 2016 | 300 | 0.120 |
Why?
|
Socioeconomic Factors | 4 | 2020 | 7841 | 0.120 |
Why?
|
Double-Blind Method | 4 | 2024 | 12430 | 0.120 |
Why?
|
Ethanol | 1 | 2000 | 1326 | 0.110 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39309 | 0.110 |
Why?
|
Peptide Fragments | 4 | 2022 | 5143 | 0.110 |
Why?
|
Hallucinations | 2 | 2013 | 373 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3511 | 0.110 |
Why?
|
Video Recording | 1 | 2018 | 976 | 0.100 |
Why?
|
Alleles | 3 | 2020 | 6895 | 0.100 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 771 | 0.100 |
Why?
|
Olfaction Disorders | 1 | 2015 | 225 | 0.100 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2012 | 139 | 0.100 |
Why?
|
Predictive Value of Tests | 8 | 2017 | 15416 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1479 | 0.090 |
Why?
|
Perception | 2 | 2015 | 1204 | 0.090 |
Why?
|
Early Diagnosis | 2 | 2014 | 1186 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12534 | 0.090 |
Why?
|
Social Support | 1 | 2021 | 2191 | 0.090 |
Why?
|
Language | 2 | 2018 | 1550 | 0.090 |
Why?
|
Patient Selection | 2 | 2021 | 4252 | 0.090 |
Why?
|
Nerve Degeneration | 1 | 2015 | 748 | 0.090 |
Why?
|
Body Mass Index | 2 | 2020 | 13050 | 0.090 |
Why?
|
Habituation, Psychophysiologic | 1 | 2011 | 144 | 0.090 |
Why?
|
Visual Perception | 3 | 2009 | 1392 | 0.080 |
Why?
|
Estradiol | 1 | 2017 | 1947 | 0.080 |
Why?
|
Severity of Illness Index | 5 | 2018 | 15908 | 0.080 |
Why?
|
Logistic Models | 4 | 2017 | 13278 | 0.080 |
Why?
|
Benzothiazoles | 1 | 2010 | 244 | 0.080 |
Why?
|
Adult | 25 | 2023 | 223307 | 0.080 |
Why?
|
Latin America | 2 | 2020 | 416 | 0.080 |
Why?
|
Prognosis | 5 | 2017 | 29948 | 0.080 |
Why?
|
Parkinson Disease | 3 | 2012 | 2884 | 0.080 |
Why?
|
Age Factors | 8 | 2018 | 18397 | 0.070 |
Why?
|
Mood Disorders | 1 | 2015 | 1127 | 0.070 |
Why?
|
Colombia | 2 | 2019 | 287 | 0.070 |
Why?
|
Postmenopause | 1 | 2017 | 2517 | 0.070 |
Why?
|
Reading | 1 | 2011 | 540 | 0.070 |
Why?
|
Australia | 2 | 2022 | 1263 | 0.070 |
Why?
|
Tropicamide | 2 | 1999 | 22 | 0.070 |
Why?
|
Statistics as Topic | 4 | 2016 | 2351 | 0.070 |
Why?
|
Feasibility Studies | 4 | 2023 | 5306 | 0.070 |
Why?
|
Computers | 2 | 2021 | 589 | 0.070 |
Why?
|
Emotions | 2 | 2016 | 2758 | 0.070 |
Why?
|
Nootropic Agents | 2 | 2012 | 159 | 0.070 |
Why?
|
Risk Assessment | 3 | 2024 | 24295 | 0.070 |
Why?
|
Health Care Costs | 1 | 2020 | 3242 | 0.070 |
Why?
|
Evoked Potentials, Visual | 1 | 2009 | 417 | 0.070 |
Why?
|
Oxygen | 3 | 2015 | 4251 | 0.070 |
Why?
|
Event-Related Potentials, P300 | 2 | 2004 | 149 | 0.070 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15657 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2015 | 1161 | 0.070 |
Why?
|
Electroencephalography | 6 | 2014 | 6282 | 0.070 |
Why?
|
Prospective Studies | 10 | 2023 | 54871 | 0.060 |
Why?
|
Pupil | 2 | 1999 | 147 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3230 | 0.060 |
Why?
|
United States | 6 | 2024 | 72951 | 0.060 |
Why?
|
Adaptation, Psychological | 1 | 2016 | 2662 | 0.060 |
Why?
|
Age of Onset | 3 | 2020 | 3342 | 0.060 |
Why?
|
Motor Activity | 1 | 2015 | 2711 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 5 | 2020 | 18075 | 0.060 |
Why?
|
Nerve Regeneration | 1 | 2010 | 796 | 0.060 |
Why?
|
Occipital Lobe | 2 | 2020 | 376 | 0.050 |
Why?
|
Memory, Short-Term | 2 | 2020 | 1004 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2016 | 3715 | 0.050 |
Why?
|
Urban Population | 1 | 2011 | 2040 | 0.050 |
Why?
|
Association | 1 | 2003 | 53 | 0.050 |
Why?
|
Genotype | 5 | 2014 | 13036 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2010 | 1827 | 0.050 |
Why?
|
Veterans | 1 | 2016 | 2667 | 0.050 |
Why?
|
Hypoxanthines | 1 | 2002 | 35 | 0.050 |
Why?
|
Survival Analysis | 1 | 2015 | 10100 | 0.050 |
Why?
|
Contrast Media | 3 | 2019 | 5329 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4047 | 0.050 |
Why?
|
Mutation | 3 | 2019 | 30213 | 0.050 |
Why?
|
Gyrus Cinguli | 2 | 2018 | 1118 | 0.050 |
Why?
|
Problem Solving | 1 | 2004 | 442 | 0.050 |
Why?
|
Mental Health | 1 | 2015 | 3270 | 0.050 |
Why?
|
Risk Factors | 9 | 2020 | 74881 | 0.050 |
Why?
|
Perceptual Disorders | 1 | 2003 | 199 | 0.050 |
Why?
|
Massachusetts | 1 | 2014 | 8891 | 0.050 |
Why?
|
Concept Formation | 1 | 2002 | 159 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1313 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2024 | 792 | 0.040 |
Why?
|
Pattern Recognition, Visual | 2 | 2005 | 820 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12064 | 0.040 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2007 | 887 | 0.040 |
Why?
|
Advisory Committees | 1 | 2024 | 797 | 0.040 |
Why?
|
Pedigree | 1 | 2007 | 4539 | 0.040 |
Why?
|
Hormones | 1 | 2023 | 866 | 0.040 |
Why?
|
Mydriatics | 1 | 1999 | 67 | 0.040 |
Why?
|
Neuronal Plasticity | 1 | 2007 | 1446 | 0.040 |
Why?
|
Analysis of Variance | 4 | 2011 | 6214 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2021 | 581 | 0.040 |
Why?
|
Demography | 2 | 2016 | 1641 | 0.040 |
Why?
|
Purines | 1 | 2002 | 615 | 0.040 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2016 | 4628 | 0.040 |
Why?
|
Spouses | 1 | 2021 | 286 | 0.040 |
Why?
|
Phenanthrolines | 1 | 2017 | 48 | 0.040 |
Why?
|
Personality | 1 | 2022 | 560 | 0.040 |
Why?
|
Cerebral Infarction | 1 | 2003 | 968 | 0.040 |
Why?
|
Boston | 2 | 2023 | 9346 | 0.040 |
Why?
|
Acoustic Stimulation | 2 | 2014 | 1253 | 0.040 |
Why?
|
Thiones | 1 | 2017 | 50 | 0.040 |
Why?
|
Palmitates | 1 | 2017 | 68 | 0.030 |
Why?
|
Color Perception | 2 | 2011 | 211 | 0.030 |
Why?
|
Vision, Ocular | 1 | 2000 | 457 | 0.030 |
Why?
|
ROC Curve | 2 | 2014 | 3620 | 0.030 |
Why?
|
Young Adult | 7 | 2020 | 59939 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 718 | 0.030 |
Why?
|
France | 1 | 2017 | 495 | 0.030 |
Why?
|
Orientation | 2 | 2011 | 314 | 0.030 |
Why?
|
Terminology as Topic | 2 | 2014 | 1540 | 0.030 |
Why?
|
Radionuclide Imaging | 2 | 2014 | 1986 | 0.030 |
Why?
|
Reproduction | 1 | 2019 | 645 | 0.030 |
Why?
|
Independent Living | 1 | 2019 | 584 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2354 | 0.030 |
Why?
|
Limbic System | 1 | 2017 | 418 | 0.030 |
Why?
|
Germany | 1 | 2017 | 882 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2021 | 1469 | 0.030 |
Why?
|
Tongue | 1 | 2017 | 406 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 6512 | 0.030 |
Why?
|
Spain | 1 | 2015 | 483 | 0.030 |
Why?
|
Health Resources | 1 | 2020 | 951 | 0.030 |
Why?
|
Neuroprotective Agents | 1 | 2019 | 956 | 0.030 |
Why?
|
Dominance, Cerebral | 1 | 1994 | 616 | 0.030 |
Why?
|
Motivation | 1 | 2023 | 2020 | 0.030 |
Why?
|
Matched-Pair Analysis | 2 | 2003 | 285 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2018 | 3359 | 0.020 |
Why?
|
Regression Analysis | 2 | 2012 | 6329 | 0.020 |
Why?
|
Apolipoprotein E3 | 1 | 2012 | 105 | 0.020 |
Why?
|
Rest | 1 | 2017 | 940 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8735 | 0.020 |
Why?
|
Indans | 1 | 2012 | 92 | 0.020 |
Why?
|
Carbon Radioisotopes | 1 | 2012 | 544 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2936 | 0.020 |
Why?
|
Levodopa | 1 | 2012 | 221 | 0.020 |
Why?
|
Adolescent | 8 | 2018 | 88904 | 0.020 |
Why?
|
Antiparkinson Agents | 1 | 2012 | 184 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2020 | 22248 | 0.020 |
Why?
|
Dopamine Agents | 1 | 2012 | 186 | 0.020 |
Why?
|
Memantine | 1 | 2012 | 110 | 0.020 |
Why?
|
Scalp | 1 | 2014 | 390 | 0.020 |
Why?
|
Body Burden | 1 | 2011 | 156 | 0.020 |
Why?
|
Chicago | 1 | 2011 | 255 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2746 | 0.020 |
Why?
|
Parents | 1 | 2024 | 3593 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 1733 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2017 | 822 | 0.020 |
Why?
|
Delusions | 1 | 2012 | 300 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13476 | 0.020 |
Why?
|
Retirement | 1 | 2011 | 198 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3138 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 2011 | 2693 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2012 | 913 | 0.020 |
Why?
|
Brain Injuries | 1 | 2000 | 2053 | 0.020 |
Why?
|
Resource Allocation | 1 | 2010 | 354 | 0.020 |
Why?
|
Behavior | 1 | 2010 | 538 | 0.020 |
Why?
|
Europe | 1 | 2014 | 3430 | 0.020 |
Why?
|
Brain Concussion | 1 | 2018 | 1431 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12985 | 0.020 |
Why?
|
Information Dissemination | 1 | 2015 | 1142 | 0.020 |
Why?
|
Animals | 4 | 2023 | 168930 | 0.020 |
Why?
|
Models, Statistical | 2 | 2011 | 5091 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2009 | 2551 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10384 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2013 | 1457 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8351 | 0.020 |
Why?
|
Individuality | 1 | 2007 | 303 | 0.020 |
Why?
|
Brain Diseases | 1 | 1994 | 1552 | 0.020 |
Why?
|
Software | 1 | 2019 | 4466 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2015 | 2116 | 0.010 |
Why?
|
Nurses | 1 | 2014 | 2503 | 0.010 |
Why?
|
Education | 1 | 2007 | 531 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2008 | 2275 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2024 | 7871 | 0.010 |
Why?
|
Phenotype | 1 | 2022 | 16724 | 0.010 |
Why?
|
Piperidines | 1 | 2012 | 1663 | 0.010 |
Why?
|
Models, Neurological | 1 | 2011 | 1747 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2010 | 1432 | 0.010 |
Why?
|
Mental Processes | 1 | 2003 | 242 | 0.010 |
Why?
|
Movement | 1 | 2008 | 1468 | 0.010 |
Why?
|
Photography | 1 | 2003 | 536 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 81635 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16044 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 8066 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20708 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 2007 | 2654 | 0.010 |
Why?
|
Biopsy | 1 | 2007 | 6779 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6207 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18330 | 0.010 |
Why?
|
Radiography | 1 | 2000 | 6968 | 0.000 |
Why?
|